GLTPD2: A Promising Drug Target for Various Diseases (G388323)

Target Name: GLTPD2

NCBI ID: G388323

GLTPD2

Other Name(s): GLTD2_HUMAN | Glycolipid transfer protein domain containing 2, transcript variant 2 | Glycolipid transfer protein domain-containing protein 2 isoform 1 precursor (isoform 1) | glycolipid transfer protein domain-containing protein 2 | Glycolipid transfer protein domain-containing protein 2 | GLTPD2 variant 2 | glycolipid transfer protein domain containing 2

GLTPD2: A Promising Drug Target for Various Diseases

GLTPD2 (GLTD2_HUMAN), a protein that belongs to the GLT family, is a promising drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. GLTPD2 has been shown to play a crucial role in multiple cellular processes, including cell signaling, DNA replication, and stress response. Its function as a drug target makes it an attractive target for researchers to develop new treatments for various diseases.

GLTPD2 is a 21-kDa protein that is expressed in most tissues of the human body. It is a key component of the GLT family, which includes several proteins that are involved in various cellular processes, including DNA replication, cell signaling, and stress response. The GLT family proteins have been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

GLTPD2 is involved in several cellular processes that are crucial for normal cellular function. One of its main functions is to regulate DNA replication in the cell. DNA replication is a critical process that ensures that the cell has an accurate copy of the genetic information. GLTPD2 plays a crucial role in regulating the DNA replication process by ensuring that the cell has the right amount of DNA and that the replication process is accurate.

GLTPD2 is also involved in cell signaling. It is a key component of several signaling pathways that are involved in various cellular processes, including cell growth, differentiation, and stress response. GLTPD2 helps to regulate these signaling pathways by ensuring that the cells have the right amount of signaling molecules and that these molecules are delivered to the right cells at the right time.

GLTPD2 is also involved in stress response. Stress can have a negative impact on the cellular function and cause various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. GLTPD2 plays a crucial role in regulating stress response by ensuring that the cells have the right amount of stress-responsive molecules and that these molecules are delivered to the right cells at the right time.

GLTPD2 is also involved in the regulation of cellular processes that are crucial for normal wound healing. Wound healing is a critical process that ensures that the body can repair itself and repair damaged tissue. GLTPD2 plays a crucial role in regulating the wound healing process by ensuring that the cells have the right amount of signaling molecules and that these molecules are delivered to the right cells at the right time.

In conclusion, GLTPD2 is a promising drug target and biomarker for various diseases. Its function as a protein that is involved in multiple cellular processes makes it an attractive target for researchers to develop new treatments for these diseases. Further research is needed to fully understand the role of GLTPD2 in the development and progression of various diseases.

Protein Name: Glycolipid Transfer Protein Domain Containing 2

The "GLTPD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLTPD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets